(Q45257524)

English

Efficacy and tolerability of tasosartan, a novel angiotensin II receptor blocker: results from a 10-week, double-blind, placebo-controlled, dose-titration study. Tasosartan Investigators Group

scientific article published in January 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Efficacy and tolerability of tasosartan, a novel angiotensin II receptor blocker: results from a 10-week, double-blind, placebo-controlled, dose-titration study. Tasosartan Investigators Group (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Neutel JM

1

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Buckalew V

2

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Chrysant SG

3

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Mroczek WJ

4

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Ruff DA

5

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Weber M

6

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

language of work or name

0 references

publication date

1 January 1999

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

American Heart Journal

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

137

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

118-125

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Historical perspective on renin system blockade in the treatment of hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970467-9

7 January 2021

Angiotensin-converting enzyme inhibitors and cough: a prospective evaluation in hypertension and in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970467-9

7 January 2021

Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970467-9

7 January 2021

Pathophysiology of silent myocardial ischemia during daily life. Hemodynamic evaluation by simultaneous electrocardiographic and blood pressure monitoring

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970467-9

7 January 2021

Pyrido[2,3-d]pyrimidine angiotensin II antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970467-9

7 January 2021

Angiotensin-converting enzyme inhibitors: past, present, and bright future

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970467-9

7 January 2021

The clinical potential of renin inhibitors and angiotensin antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970467-9

7 January 2021

Reversal of left ventricular hypertrophy in hypertensive patients. A metaanalysis of 109 treatment studies

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970467-9

7 January 2021

Captopril reduces aortic and microvascular growth in hypertensive and normotensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970467-9

7 January 2021

A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970467-9

7 January 2021

Renal hemodynamics and reduction of proteinuria by a vasodilating beta blocker versus an ACE inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970467-9

7 January 2021

Angiotensin I converting enzyme and the changes in our concepts through the years. Lewis K. Dahl memorial lecture

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970467-9

7 January 2021

Chronic kinin receptor blockade attenuates the antihypertensive effect of ramipril

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970467-9

7 January 2021

Cough and ACE inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970467-9

7 January 2021

Safety and tolerability of losartan potassium, an angiotensin II receptor antagonist, compared with hydrochlorothiazide, atenolol, felodipine ER, and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970467-9

7 January 2021

Circadian variation in the frequency of onset of acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970467-9

7 January 2021

Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970467-9

7 January 2021

Angiotensin converting enzyme inhibitors. Present and future

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970467-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0002-8703(99)70467-9

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45257524&oldid=2078219247"